Quantcast

Latest CD133 Stories

2013-02-08 23:03:54

Stem cells taken from ALS patients may have the same capacity to develop into mature neuron-like cells as those collected from healthy donors, according to a new study released this month in STEM

2010-04-08 09:10:37

A nutritional supplement could stimulate the production of stem cells integral for repairing the body.

2010-02-03 22:39:03

Researchers at the Pontifícia Universidade Católica do Paraná and Instituto Carlos Chagas have evaluated the therapeutic potential of purified and expanded CD133+ cells human umbilical cord blood (HUCB)-derived in treating myocardial infarction by intramyocardially injecting them into a rat model.

2009-10-29 10:05:00

BERGISCH GLADBACH, Germany, October 29 /PRNewswire/ -- Miltenyi Biotec announces the treatment of the first patient in a phase III clinical trial termed PERFECT.

2008-10-10 09:00:52

ImmunoCellular Therapeutics, a biotechnology company, has filed a provisional US patent application relating to its vaccine technology targeting cancer stem cells. The vaccine technology is exclusively licensed from Cedars-Sinai Medical Center.

2008-07-10 09:01:29

ImmunoCellular Therapeutics has exclusively licensed from Cedars-Sinai Medical Center, certain novel peptides which can stimulate the immune system to target cancer stem cells in gliomas, a cancer originating in the brain or spine.


Word of the Day
shotta
  • An armed gangster.
The word 'shotta' is an alteration of 'shooter'.